Your browser doesn't support javascript.
loading
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204).
Chakravarthy, A Bapsi; Zhao, Fengmin; Meropol, Neal J; Flynn, Patrick J; Wagner, Lynne I; Sloan, Jeffrey; Diasio, Robert B; Mitchell, Edith P; Catalano, Paul; Giantonio, Bruce J; Catalano, Robert B; Haller, Daniel G; Awan, Rashid A; Mulcahy, Mary F; O'Brien, Timothy E; Santala, Roger; Cripps, Christine; Weis, John R; Atkins, James N; Leichman, Cynthia G; Petrelli, Nicholas J; Sinicrope, Frank A; Brierley, James D; Tepper, Joel E; O'Dwyer, Peter J; Sigurdson, Elin R; Hamilton, Stanley R; Cella, David; Benson, Al B.
Affiliation
  • Chakravarthy AB; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Zhao F; ECOG-ACRIN Biostatistics Center, Boston, Massachusetts, USA.
  • Meropol NJ; Flatiron Health, New York, New York, USA.
  • Flynn PJ; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA.
  • Wagner LI; Abbott-Northwestern Hospital, Minneapolis, Minnesota, USA.
  • Sloan J; Wake Forest University Health Sciences, Winston Salem, North Carolina, USA.
  • Diasio RB; Mayo Clinic, Rochester, Minnesota, USA.
  • Mitchell EP; Mayo Clinic, Rochester, Minnesota, USA.
  • Catalano P; Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
  • Giantonio BJ; ECOG-ACRIN Biostatistics Center, Boston, Massachusetts, USA.
  • Catalano RB; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.
  • Haller DG; Drexel University, Philadelphia, Pennsylvania, USA.
  • Awan RA; University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Mulcahy MF; University of Pittsburgh Cancer Institute (UPCI), Johnstown, Pennsylvania, USA.
  • O'Brien TE; Northwestern University, Chicago, Illinois, USA.
  • Santala R; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA.
  • Cripps C; Montana Cancer Consortium, Billings, Montana, USA.
  • Weis JR; Ottawa Health Research Institute-General Division, Ottawa, Ontario, Canada.
  • Atkins JN; Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, USA.
  • Leichman CG; Southeast Cancer Control Consortium, Winston-Salem, North Carolina, USA.
  • Petrelli NJ; Laura and Issac Perlmutter Cancer Center at NYU Langone, New York, New York, USA.
  • Sinicrope FA; Delaware/Christiana Care NCORP, Newark, Delaware, USA.
  • Brierley JD; Mayo Clinic, Rochester, Minnesota, USA.
  • Tepper JE; University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada.
  • O'Dwyer PJ; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Sigurdson ER; University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Hamilton SR; Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Cella D; MD Anderson Cancer Center, Houston, Texas, USA.
  • Benson AB; Northwestern University, Chicago, Illinois, USA.
Oncologist ; 25(5): e798-e807, 2020 05.
Article in En | MEDLINE | ID: mdl-31852811
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Rectal Neoplasms / Fluorouracil Type of study: Clinical_trials Language: En Journal: Oncologist Year: 2020 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Rectal Neoplasms / Fluorouracil Type of study: Clinical_trials Language: En Journal: Oncologist Year: 2020 Type: Article Affiliation country: United States